SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Can you beat 50% per month? -- Ignore unavailable to you. Want to Upgrade?

To: Leebert who wrote (10690)3/29/2007 4:52:41 PM
From: Leebert  Respond to of 19256
 
WASHINGTON -- A Food and Drug Administration panel of outside medical experts Thursday backed a proposed prostate-cancer treatment designed to stimulate a person's immune system to fight the cancer despite concerns the drug might not be that effective.

The panel unanimously said the proposed treatment, Provenge by Dendreon Corp., Seattle, was safe. It also said the FDA should consider approving the drug ...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News